X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5648) 5648
Book Review (1473) 1473
Publication (392) 392
Newsletter (280) 280
Book Chapter (40) 40
Newspaper Article (16) 16
Conference Proceeding (15) 15
Magazine Article (15) 15
Dissertation (11) 11
Book / eBook (2) 2
Reference (2) 2
Trade Publication Article (2) 2
Transcript (2) 2
Data Set (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4495) 4495
warfarin (4356) 4356
humans (4070) 4070
male (1996) 1996
pharmacology & pharmacy (1854) 1854
female (1656) 1656
anticoagulants (1553) 1553
aged (1245) 1245
middle aged (1191) 1191
anticoagulants - administration & dosage (1168) 1168
pharmacokinetics (1135) 1135
anticoagulants - therapeutic use (1133) 1133
drug interactions (1042) 1042
warfarin - administration & dosage (963) 963
adult (957) 957
anticoagulants - adverse effects (939) 939
atrial fibrillation (910) 910
warfarin - pharmacokinetics (889) 889
anticoagulants - pharmacokinetics (826) 826
administration, oral (825) 825
dabigatran (817) 817
warfarin - therapeutic use (811) 811
international normalized ratio (749) 749
hematology (717) 717
stroke (715) 715
warfarin - adverse effects (679) 679
anticoagulation (672) 672
rivaroxaban (660) 660
analysis (613) 613
animals (599) 599
therapy (587) 587
cardiac & cardiovascular systems (583) 583
prevention (571) 571
pharmacogenetics (570) 570
risk factors (569) 569
peripheral vascular disease (566) 566
research (566) 566
thromboembolism (565) 565
aged, 80 and over (562) 562
abridged index medicus (556) 556
atrial-fibrillation (555) 555
atrial fibrillation - drug therapy (551) 551
hemorrhage - chemically induced (532) 532
drug therapy (531) 531
dose-response relationship, drug (521) 521
warfarin - pharmacology (500) 500
cyp2c9 (490) 490
venous thromboembolism (486) 486
medicine & public health (477) 477
risk (470) 470
pharmacodynamics (467) 467
anticoagulants - pharmacology (461) 461
treatment outcome (458) 458
metabolism (448) 448
genotype (446) 446
stroke - prevention & control (446) 446
apixaban (443) 443
dosage and administration (438) 438
medicine, general & internal (425) 425
cytochrome p-450 cyp2c9 (419) 419
management (415) 415
care and treatment (405) 405
pharmacology (397) 397
atrial fibrillation - complications (385) 385
health aspects (368) 368
cytochrome p-450 (365) 365
thrombin (362) 362
thrombosis (357) 357
aryl hydrocarbon hydroxylases - genetics (353) 353
drugs (343) 343
blood coagulation - drug effects (342) 342
safety (338) 338
stroke prevention (319) 319
internal medicine (318) 318
patients (314) 314
warfarin - blood (313) 313
oral anticoagulants (312) 312
bleeding (310) 310
rats (305) 305
cardiology (303) 303
prothrombin time (299) 299
retrospective studies (299) 299
vkorc1 (290) 290
pharmacology/toxicology (286) 286
hemorrhage (282) 282
antithrombotic therapy (280) 280
thromboembolism - prevention & control (280) 280
warfarin - metabolism (280) 280
dabigatran etexilate (275) 275
cardiac arrhythmia (272) 272
usage (256) 256
complications and side effects (254) 254
time factors (250) 250
clinical trials (240) 240
aspirin (238) 238
adolescent (236) 236
stroke - etiology (236) 236
algorithms (234) 234
vitamin k epoxide reductases (233) 233
surgery (232) 232
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5847) 5847
Japanese (34) 34
German (31) 31
French (27) 27
Russian (21) 21
Spanish (11) 11
Chinese (8) 8
Czech (5) 5
Portuguese (4) 4
Italian (3) 3
Korean (3) 3
Polish (3) 3
Turkish (3) 3
Swedish (2) 2
Danish (1) 1
Hungarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Book
Journal Article
Journal Article
Advances in Therapy, ISSN 0741-238X, 2/2012, Volume 29, Issue 2, pp. 163 - 177
Coronary heart disease, stroke, and peripheral vascular disease are the most common causes of mortality in patients with type 2 diabetes mellitus (T2DM). The... 
dapagliflozin | pharmacodynamics | Rheumatology | simvastatin | sodium glucose co-transporter-2 | Internal Medicine | Oncology | digoxin | warfarin | type 2 diabetes | Medicine & Public Health | pharmacokinetics | valsartan | Cardiology | Pharmacology/Toxicology | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | SELECTIVE SGLT2 INHIBITOR | HEALTHY-SUBJECTS | HUMANS | INADEQUATE GLYCEMIC CONTROL | DIABETES-MELLITUS | POTENT | HYPERGLYCEMIA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TYPE-2 | ASSOCIATION | Hypoglycemic Agents - pharmacokinetics | Benzhydryl Compounds | Valsartan | Valine - pharmacokinetics | Humans | Middle Aged | Valine - analogs & derivatives | Male | Glucosides - pharmacokinetics | Antihypertensive Agents - pharmacokinetics | Simvastatin - pharmacokinetics | Anti-Arrhythmia Agents - pharmacokinetics | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Digoxin - pharmacokinetics | Warfarin - pharmacokinetics | Cross-Over Studies | Anticholesteremic Agents - pharmacokinetics | Drug Interactions | Adult | Female | Anticoagulants - pharmacokinetics | Diabetes Mellitus, Type 2 - drug therapy | Tetrazoles - pharmacokinetics | Type 2 diabetes | Warfarin | Digoxin | Simvastatin | Drug interactions | Anticoagulants (Medicine) | Glucose | Dextrose | Antilipemic agents | Cardiac glycosides | Blood circulation disorders | Cardiotonic agents | Cardiac patients | Diabetes | Heart diseases | Health technology assessment
Journal Article
British Journal of Surgery, ISSN 0007-1323, 06/2014, Volume 101, Issue 7, pp. 742 - 749
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2014, Volume 70, Issue 11, pp. 1339 - 1351
Journal Article
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 12/2012, Volume 40, Issue 12, pp. 2250 - 2255
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 163, Issue 6, pp. 931 - 937.e1
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 12/2009, Volume 68, Issue 6, pp. 928 - 935
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Numerous cocktails using concurrent administration of several cytochrome P450 (CYP) isoform-selective probe drugs... 
in vivo drug-drug interaction | cocktail | CYP | Cocktail | In vivo drug-drug interaction | DRUG | CAFFEINE | COMBINED PHENOTYPIC ASSESSMENT | METOPROLOL | OMEPRAZOLE TREATMENT | XANTHINE-OXIDASE | METABOLISM | ENZYMES | IN-VIVO | N-ACETYLTRANSFERASE-2 | PHARMACOLOGY & PHARMACY | Anti-Anxiety Agents - administration & dosage | Caffeine - administration & dosage | Anticoagulants - administration & dosage | Area Under Curve | Humans | Midazolam - administration & dosage | Cytochrome P-450 CYP1A2 - administration & dosage | Male | Metabolic Clearance Rate | Warfarin - administration & dosage | Caffeine - pharmacokinetics | Anti-Ulcer Agents - pharmacokinetics | Young Adult | Anti-Anxiety Agents - pharmacokinetics | Drug Interactions | Adult | Drug Therapy, Combination | Administration, Oral | Omeprazole - administration & dosage | Omeprazole - pharmacokinetics | Midazolam - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Central Nervous System Stimulants - pharmacokinetics | Anticoagulants - pharmacokinetics | Central Nervous System Stimulants - administration & dosage | Drug Combinations | Cytochrome P-450 CYP1A2 - pharmacokinetics | Omeprazole | Warfarin | Analysis | Drug interactions | Cytochrome P-450 | Physiological aspects | Liquid chromatography | Mass spectrometry | Caffeine | Index Medicus | Drug Metabolism | in vivo drug–drug interaction
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 01/2012, Volume 73, Issue 1, pp. 66 - 76
Journal Article